Capillary Applied sciences shares rocket as much as 13% after tepid debut. Must you purchase, promote or maintain the inventory?
In a subdued debut, Capillary Applied sciences India listed at a 2.9% low cost to its subject worth of Rs 577 on the BSE, opening at Rs 560. On the NSE, the inventory started buying and selling at Rs 571.90, a 0.9% low cost to the IPO worth. Sentiment, nevertheless, shifted quickly as shopping for curiosity picked up by the session.
On the BSE, the inventory climbed to an intraday excessive of Rs 633, up 13% from the opening print. On the NSE, it surged as a lot as 10.8%, hitting Rs 633.9 from its opening degree of Rs 571.9.
The sturdy transfer got here regardless of the gray market outlook turning out to be extra optimistic than actuality at itemizing. The final GMP for the Capillary Applied sciences IPO stood at Rs 55 earlier than the inventory hit the exchanges, implying an anticipated revenue of 9.53%. As an alternative, the shares opened at a roughly 3% low cost.
Capillary Applied sciences IPO snapshot
The Rs 878 crore subject, which closed on November 18, noticed heavy demand throughout classes. Certified institutional patrons (QIBs) subscribed 57.3 instances, non-institutional traders (NIIs) bid 69.85 instances and retail traders subscribed 15.85 instances.
Forward of the general public subject, the corporate raised Rs 393.98 crore from anchor traders on November 13, allotting 68.28 lakh shares to international and home establishments.
The IPO consisted of a recent subject of Rs 345.2 crore and a suggestion on the market price Rs 532.5 crore, with shares priced at Rs 577 apiece — the highest finish of the value band.
Must you purchase, promote or maintain Capillary Applied sciences?
Shivani Nyati, Head of Wealth at Swastika Investmart, weighed in on the inventory’s debut and outlook, and mentioned the subdued itemizing signifies cautious investor sentiment regardless of Capillary’s sturdy positioning as a SaaS-based buyer engagement and loyalty options supplier serving main retail and client manufacturers throughout India and international markets. She mentioned Capillary’s core strengths stay intact.
“Capillary’s strengths lie in its AI-driven loyalty administration platform, deep enterprise consumer relationships, sturdy presence throughout Asia and the Center East, and constant income development pushed by subscription-based recurring revenue. Its diversified product suite—spanning loyalty applications, buyer knowledge platforms, and engagement automation—gives scalability and long-term development visibility,” mentioned Nyati, nevertheless, she cautioned that the market is weighing significant dangers.
Buyers stay cautious attributable to excessive competitors within the SaaS and martech house, elevated buyer acquisition prices, and the corporate’s want to boost profitability to justify valuations,” mentioned Nyati.
On technique for traders who obtained shares within the IPO, Nyati mentioned “given the discounted itemizing, traders and merchants allotted shares might think about holding the inventory with a medium-term to long-term perspective, whereas retaining a strict stop-loss close to Rs 520 to handle draw back threat.”
Capillary’s enterprise and funds
Capillary Applied sciences is amongst India’s main SaaS firms in buyer loyalty, omnichannel CRM and AI-led engagement. Its software program stack helps greater than 250 manufacturers throughout 30 nations, together with Tata, Shell, Domino’s, Jockey and PUMA. Income is primarily generated by subscription charges, advertising and marketing automation companies, analytics instruments and enterprise loyalty platforms.
The corporate’s monetary profile has improved in recent times. After posting losses by FY24, Capillary turned worthwhile in FY25, reporting a PAT of Rs 14.15 crore in contrast with a lack of Rs 68.35 crore within the earlier yr. Whole revenue rose 14% year-on-year to Rs 611.87 crore. For the six months ended September 2025, income stood at Rs 362.56 crore, whereas revenue got here in at Rs 1.03 crore.
Proceeds from the recent subject shall be used to increase cloud infrastructure, increase analysis and product growth, strengthen IT {hardware} and fund potential acquisitions. Round Rs 143 crore is allotted for cloud infrastructure prices, with one other Rs 71.58 crore earmarked for R&D investments.
Brokerages famous that Capillary’s SaaS-led, recurring-revenue mannequin gives sturdy visibility and consumer stickiness, but additionally flagged that valuations stay aggressive.
Additionally learn | Capillary Applied sciences shares make tepid begin, checklist at 3% low cost to IPO worth
(Disclaimer: Suggestions, recommendations, views and opinions given by the specialists are their very own. These don’t characterize the views of the Financial Instances)
